TOMASSINI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.734
AS - Asia 940
EU - Europa 920
SA - Sud America 152
OC - Oceania 10
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.767
Nazione #
US - Stati Uniti d'America 1.710
SG - Singapore 719
IE - Irlanda 272
IT - Italia 239
BR - Brasile 137
CN - Cina 103
RU - Federazione Russa 82
SE - Svezia 72
DE - Germania 69
GB - Regno Unito 60
VN - Vietnam 34
HK - Hong Kong 32
FI - Finlandia 26
FR - Francia 15
CA - Canada 14
UA - Ucraina 14
AT - Austria 13
TR - Turchia 10
AU - Australia 9
BD - Bangladesh 9
BE - Belgio 9
IN - India 9
CZ - Repubblica Ceca 8
AR - Argentina 7
ES - Italia 7
NL - Olanda 7
RO - Romania 7
IR - Iran 5
BG - Bulgaria 4
JP - Giappone 4
PA - Panama 4
PK - Pakistan 4
CH - Svizzera 3
PL - Polonia 3
VE - Venezuela 3
ZA - Sudafrica 3
EU - Europa 2
IQ - Iraq 2
JM - Giamaica 2
KE - Kenya 2
MD - Moldavia 2
MX - Messico 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
MA - Marocco 1
MC - Monaco 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 3.767
Città #
Singapore 533
Chandler 286
Dublin 268
Santa Clara 149
Ashburn 109
The Dalles 100
Jacksonville 83
Princeton 82
Altamura 41
Los Angeles 38
Beijing 33
Dong Ket 33
Hong Kong 32
Wilmington 29
Munich 24
Nuremberg 23
Rome 21
Washington 21
Chieti 17
Seattle 17
New York 16
Ann Arbor 15
Pescara 15
Romola 14
Helsinki 13
London 13
Teramo 13
Falls Church 12
Milan 12
Boardman 11
Camerino 10
Chicago 10
Moscow 10
São Paulo 10
Brooklyn 9
Brussels 9
Fairfield 8
Lappeenranta 8
Southend 8
Castignano 7
Frankfurt am Main 7
Saint Petersburg 7
Woodbridge 7
Boston 6
Nanchang 6
Norwalk 6
Rio de Janeiro 6
Santander 6
Sydney 6
Cardiff 5
Dallas 5
Düsseldorf 5
Istanbul 5
Oxford 5
Pune 5
Silvi 5
Tehran 5
Belo Horizonte 4
Brno 4
Edinburgh 4
Guangzhou 4
Houston 4
Izmir 4
Brasília 3
Hanover 3
Juiz de Fora 3
Kensington 3
Lauterbourg 3
Menlo Park 3
Montreal 3
Naples 3
Olomouc 3
Ottawa 3
Panama City 3
Phoenix 3
San Vito Chietino 3
Secaucus 3
Shanghai 3
Tokyo 3
Toronto 3
Turku 3
Vienna 3
Wuhan 3
Anápolis 2
Araucária 2
Betim 2
Bosio 2
Cambridge 2
Caxias do Sul 2
Cedar Lake 2
Chennai 2
Città Sant'Angelo 2
Contagem 2
Cuiabá 2
Curitiba 2
Dearborn 2
Elk Grove Village 2
Florence 2
Genoa 2
Goiânia 2
Totale 2.377
Nome #
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. 86
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis 86
Modelling the natural history of primary progressive multiple sclerosis 85
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 83
A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI 83
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 82
Neuroplasticity and motor rehabilitation in multiple sclerosis 79
Tractography in the presence of multiple sclerosis lesions 77
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis 76
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis 75
Oral contraceptives combined with interferon b in multiple sclerosis 74
Brain morphometry in Multiple Sclerosis 73
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 72
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 71
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI 67
Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity 65
Neurological update: MOG antibody disease 65
How common is truly benign MS in a UK population? 65
Predicting the profile of increasing disability in multiple sclerosis 64
Informing MS patients on treatment options: a consensus on the process of consent taking 61
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression 61
Site-specific clinical disease onset in multiple sclerosis 60
Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study 60
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 60
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 59
A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO 2) 57
Cerebral Metabolic Changes During Visuomotor Adaptation Assessed Using Quantitative fMRI 56
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis 55
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial 55
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation 53
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 50
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging 49
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis 49
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases 49
Medical education and MS: getting the training right 48
Diagnosis and management of multiple sclerosis: MRI in clinical practice 46
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 46
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 44
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 41
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 41
Corrigendum: A Frequency-Domain Machine Learning Method for Dual-Calibrated fMRI Mapping of Oxygen Extraction Fraction (OEF) and Cerebral Metabolic Rate of Oxygen Consumption (CMRO 2) 40
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 40
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS 40
The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis 39
Breath-hold BOLD fMRI without CO2 sampling enables estimation of venous cerebral blood volume: potential use in normalization of stimulus-evoked BOLD fMRI data 38
Similarities and differences between multiple sclerosis and type 1 diabetes 38
Age-related changes in grey and white matter structure throughout adulthood 37
Preservation of motor skill learning in patients with multiple sclerosis 35
Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’ 35
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study 35
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 34
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis 34
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta 34
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis 34
Neuroplasticity and functional recovery in multiple sclerosis 33
Lessons from immunotherapies in multiple sclerosis 33
Contemporary study of multiple sclerosis disability in South East Wales 33
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 32
Relating brain damage to brain plasticity in patients with multiple sclerosis 32
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 32
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial 30
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study 30
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 30
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis 30
Model-free characterization of brain functional networks for motor sequence learning using fMRI 29
Structural and functional bases for individual differences in motor learning 29
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis 29
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 29
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability 28
Diffusion-Weighted Imaging Tractography-Based Parcellation of the Human Parietal Cortex and Comparison with Human and Macaque Resting-State Functional Connectivity 28
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis 27
Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis 27
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study 27
Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI 27
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis 26
Changes in brain perfusion with training-related visuomotor improvement in MS 25
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge 24
Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience 24
Multiple sclerosis lesions: insights from imaging techniques 24
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis 24
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity 23
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 23
Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke 22
A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis 22
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 22
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study 22
Sex hormones, brain damage and clinical course of Multiple Sclerosis 21
Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model 20
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 20
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years 19
Sex hormones: a role in the control of multiple sclerosis? 18
Alexithymia in multiple sclerosis: relationship with fatigue and depression 17
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence 16
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence 16
"Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression 15
FACS-Proteomics strategy toward extracellular vesicles single-phenotype characterization in biological fluids: exploring the role of leukocyte-derived EVs in multiple sclerosis 15
Investigating social cognition in Multiple Sclerosis: Does Implicit Biological Motion processing affect visuo-spatial attention? 15
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis 15
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride 13
Transverse myelitis in children and adults 12
Totale 4.149
Categoria #
all - tutte 24.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 0 0 0 13
2020/2021185 21 18 35 7 2 29 8 14 6 5 0 40
2021/2022209 1 1 3 3 8 12 3 37 25 5 17 94
2022/2023889 76 131 41 85 70 143 57 62 100 42 46 36
2023/2024640 52 21 55 24 32 184 116 41 15 33 14 53
2024/20251.973 120 544 421 52 47 58 76 82 192 147 161 73
Totale 4.149